Hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-03-05Clinical Trial Update: IGEV Followed by Autologous Transplantation for Refractory or Relapsed Hodgkin Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating the IGEV chemotherapy regimen followed by autologous stem cell transplantation in patients with refracto…
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: Aminocamptothecin in Treating Patients With Refractory or Recurrent Hodgkin's Disease or Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 trial evaluating aminocamptothecin in patients with refractory or recurrent Hodgkin lymphoma or non-Hodgkin lymphoma has been comp…
-
CLINICAL_TRIALS trial_result · 2013-02-07Clinical Trial Update: 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma [Phase 1]
This Phase 1 trial evaluated the Hsp90 inhibitor tanespimycin (17-AAG) in patients with advanced epithelial cancers, malignant lymphomas, or…
-
CLINICAL_TRIALS trial_result · 2013-02-07Clinical Trial Update: Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction [Phase 1]
This clinical trial update summarizes a Phase 1 study of Imatinib Mesylate in patients with advanced cancer and liver dysfunction, which has…
-
CLINICAL_TRIALS trial_result · 2013-02-05Clinical Trial Update: S0410 Tandem Stem Cell Transplantation in Treating Patients With Progressive or Recurrent Hodgkin's Lymphoma [Phase 2]
Phase 2 study evaluating tandem stem cell transplantation in patients with progressive or recurrent Hodgkin lymphoma; results were posted af…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-02-04FDA Approved: DOXORUBICIN HYDROCHLORIDE — Original Application (BluePoint Laboratories)
FDA approved a generic doxorubicin hydrochloride product under Original Application for BluePoint Laboratories (ANDA 203263). This marks app…
-
CLINICAL_TRIALS trial_result · 2013-02-01Clinical Trial Update: Study of a-Interferon With Adriamycin, Bleomycin, Velban, and Dacarbazine (ABVD) With Hodgkin's Disease [Phase 2]
Phase 2 clinical trial evaluating the addition of alpha-interferon to the ABVD chemotherapy regimen for Hodgkin lymphoma; the study complete…
-
CLINICAL_TRIALS trial_result · 2013-01-25Clinical Trial Update: 17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphomas [Phase 1]
Phase 1 clinical trial evaluating 17-DMAG (alvespimycin), an HSP90 inhibitor, in patients with metastatic or unresectable solid tumors or ly…
-
CLINICAL_TRIALS trial_result · 2013-01-25Clinical Trial Update: Oblimersen and Gemcitabine in Treating Patients With Advanced Solid Tumor or Lymphoma [Phase 1]
An update on a Phase 1 trial of oblimersen in combination with gemcitabine for patients with advanced solid tumors or lymphoma, which has be…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: MS-275 and Isotretinoin in Treating Patients With Metastatic or Advanced Solid Tumors or Lymphomas [Phase 1]
This Phase 1 trial evaluated entinostat (MS-275) plus isotretinoin in adults with metastatic or advanced solid tumors or various lymphomas; …
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: CCI-779 in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia [Phase 2]
Phase 2 study of temsirolimus (CCI-779) in relapsed or refractory chronic lymphocytic leukemia has been terminated. The study also involved …
-
CLINICAL_TRIALS other · 2013-01-24Clinical Trial Update: S9901 Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Men With Stage III or Stage IV Hodgkin's Disease [Phase 3]
This is a clinical trial update indicating that the phase 3 study of combination chemotherapy with or without peripheral stem cell transplan…
-
CLINICAL_TRIALS research · 2013-01-17Clinical Trial Update: Radiolabeled Monoclonal Antibody With or Without Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Lymphoma [Phase 1]
Phase 1 trial evaluating a radiolabeled monoclonal antibody with or without peripheral stem cell transplantation in children with recurrent …
-
CLINICAL_TRIALS trial_result · 2013-01-14Clinical Trial Update: SB-715992 in Treating Patients With Metastatic or Unresectable Solid Tumors or Hodgkin's or Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 trial of SB-715992 in patients with metastatic or unresectable solid tumors and various Hodgkin's and non-Hodgkin's lymphomas has be…
-
CLINICAL_TRIALS trial_result · 2013-01-09Clinical Trial Update: Prevention of Ovarian Function Damage by a GnRH Analogue During Chemotherapy in Hodgkin Lymphoma Patients [NA]
This completed clinical trial evaluated whether giving a GnRH analogue during chemotherapy can prevent ovarian function damage in Hodgkin ly…
-
CLINICAL_TRIALS trial_result · 2013-01-08Clinical Trial Update: Gemcitabine, Cisplatin, and Dexamethasone in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating gemcitabine, cisplatin, and dexamethasone in patients with relapsed or refractory Hodgkin lymphoma.
-
CLINICAL_TRIALS trial_result · 2012-12-20Clinical Trial Update: Pulmonary Function in Patients With Hodgkin's Disease Receiving Bleomycin-Based Chemotherapy
This update reports on a completed clinical trial evaluating pulmonary function in Hodgkin lymphoma patients treated with bleomycin-based ch…
-
CLINICAL_TRIALS trial_result · 2012-12-18Clinical Trial Update: Positron Emission Tomography(PET) in Lymphoma Assessment [NA]
Clinical trial update on PET imaging for Hodgkin lymphoma and Non-Hodgkin lymphoma assessment reports the study status as completed.
-
CLINICAL_TRIALS trial_result · 2012-12-07Clinical Trial Update: Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated Donor [Phase 2]
Phase 2 study evaluating parathyroid hormone after sequential cord blood transplantation from an unrelated donor; the trial was terminated a…
-
CLINICAL_TRIALS trial_result · 2012-12-06Clinical Trial Update: Phase 1 Study of MDX-1401 in Patients With CD30-positive Refractory/Relapsed Hodgkin's Lymphoma [Phase 1]
A Phase 1 study evaluating MDX-1401 in patients with CD30-positive relapsed or refractory Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2012-11-12Clinical Trial Update: High Dose Chemotherapy Followed By PBSC Rescue for HD [NA]
This is a completed clinical trial from Stanford University evaluating high-dose chemotherapy followed by peripheral blood stem cell rescue …
-
CLINICAL_TRIALS trial_result · 2012-11-06Clinical Trial Update: Giving Gene Marked EBV Specific T-Cells to Patients Receiving a BMT for Relapsed EBV-Positive Hodgkin Disease [Phase 1]
A Phase 1 clinical trial update describes giving gene-marked EBV-specific T-cells to patients receiving a bone marrow transplant for relapse…
-
CLINICAL_TRIALS trial_result · 2012-10-04Clinical Trial Update: Combination Chemotherapy With or Without Amifostine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Disease Undergoing Stem Cell Transplantation [Phase 2]
This Phase 2 trial evaluates adding amifostine to chemotherapy versus chemotherapy alone in patients with recurrent or refractory non-Hodgki…
-
CLINICAL_TRIALS trial_result · 2012-09-19Clinical Trial Update: Vorinostat in Treating Patients With Relapsed or Refractory Advanced Hodgkin's Lymphoma [Phase 2]
Phase 2 clinical trial of vorinostat in adults with relapsed or refractory advanced Hodgkin lymphoma has completed, with results posted in 2…
-
CLINICAL_TRIALS trial_result · 2012-09-18Clinical Trial Update: Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating pralatrexate and gemcitabine with B12 and folic acid in relapsed/refractory lymphoproliferative malignan…